Nuzenio

Gurufocus United Therapeutics

Gurufocus United Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 20:38:28 GMTUTHR Maintained by RBC Capital -- Price Target Lowered to $677 - GuruFocus
Thu, 06 Aug 2026 06:11:50 GMTUTHR SWOT Analysis: Strong Financial Health Amidst Market Challe - GuruFocus
Thu, 06 Aug 2026 03:36:04 GMTAvoro Capital Advisors LLC Acquires Stake in Scribe Therapeutics Inc (SCTX) - GuruFocus
Thu, 06 Aug 2026 01:11:39 GMTUnited Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highligh - GuruFocus
Wed, 05 Aug 2026 21:01:45 GMTUnited Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress ... - Yahoo Finance
Wed, 05 Aug 2026 13:10:43 GMTUTHR Looks 33.8% Overvalued on GF Value™ - GuruFocus

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gurufocus United Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.